JP2007509984A5 - - Google Patents

Download PDF

Info

Publication number
JP2007509984A5
JP2007509984A5 JP2006538385A JP2006538385A JP2007509984A5 JP 2007509984 A5 JP2007509984 A5 JP 2007509984A5 JP 2006538385 A JP2006538385 A JP 2006538385A JP 2006538385 A JP2006538385 A JP 2006538385A JP 2007509984 A5 JP2007509984 A5 JP 2007509984A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pedf
composition according
peptide
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006538385A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007509984A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/036245 external-priority patent/WO2005041887A2/en
Publication of JP2007509984A publication Critical patent/JP2007509984A/ja
Publication of JP2007509984A5 publication Critical patent/JP2007509984A5/ja
Pending legal-status Critical Current

Links

JP2006538385A 2003-10-29 2004-10-29 色素上皮由来因子、その新規な生物活性及びその使用方法 Pending JP2007509984A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51537403P 2003-10-29 2003-10-29
PCT/US2004/036245 WO2005041887A2 (en) 2003-10-29 2004-10-29 Pigment epithelium-derived factor, novel biological activity and methods of use

Publications (2)

Publication Number Publication Date
JP2007509984A JP2007509984A (ja) 2007-04-19
JP2007509984A5 true JP2007509984A5 (enExample) 2007-12-13

Family

ID=34549400

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006538385A Pending JP2007509984A (ja) 2003-10-29 2004-10-29 色素上皮由来因子、その新規な生物活性及びその使用方法

Country Status (6)

Country Link
US (1) US20080293626A1 (enExample)
EP (1) EP1684692A2 (enExample)
JP (1) JP2007509984A (enExample)
CN (1) CN101014358A (enExample)
AU (1) AU2004285562B2 (enExample)
WO (1) WO2005041887A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006054278A2 (en) 2004-11-16 2006-05-26 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Variants of pigment epithelium derived factor and uses thereof
US8841259B2 (en) 2005-02-24 2014-09-23 Joslin Diabetes Center Compositions and methods for treating vascular permeability
CA2629519A1 (en) 2005-11-14 2007-05-18 Yeda Research & Development Co. Ltd. At The Weizmann Institute Of Scienc E Improved variants of pigment epithelium derived factor and uses thereof
WO2007095350A2 (en) * 2006-02-15 2007-08-23 Yale University Compositions and methods for use of pigment epithelial derived factor (pedf) peptide fragments
ES2329636B2 (es) * 2006-02-17 2010-07-26 Universitat De Valencia, Estudi General (Participa Con El 70%) Uso del factor pedf para inducir la auto-renovacion de celulas madre.
US20100119512A1 (en) * 2007-01-25 2010-05-13 Joslin Diabetes Center Methods of diagnosing, treating, and preventing increased vascular permeability
JPWO2009116529A1 (ja) 2008-03-18 2011-07-21 国立大学法人北海道大学 ポリペプチドおよび当該ポリペプチドを含む医薬組成物
CA2776748A1 (en) * 2009-10-08 2011-04-14 Neurotech Usa, Inc. Use of pedf in an encapsulated cell-based delivery system
EP2508196B1 (en) * 2011-03-23 2018-09-26 Mackay Memorial Hospital Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing
US20130046283A1 (en) * 2011-05-05 2013-02-21 Medtronic Vascular, Inc. Methods and intravascular treatment devices for treatment of atherosclerosis
TWI554521B (zh) * 2011-10-19 2016-10-21 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 色素上皮衍生因子衍生之多胜肽於治療禿髮和/或毛髮脫色之用途
CN102757497B (zh) * 2012-07-16 2014-09-17 中山大学 一种抗pedf单克隆抗体及其制备方法和应用
US9938328B2 (en) 2012-09-17 2018-04-10 Mackay Memorial Hospital Use of PEDF-derived polypeptides for treating alopecia and/or hair depigmentation
JP6484174B2 (ja) * 2012-09-19 2019-03-20 マクカイ メモリアル ホスピタル 皮膚老化を予防及び/又は改善するためのpedf−由来ポリペプチドの使用
TWI449532B (zh) * 2012-09-19 2014-08-21 Mackay Memorial Hospital 色素上皮衍生因子衍生之多胜肽於預防和/或緩和皮膚老化之用途
US9777048B2 (en) 2012-09-20 2017-10-03 Mackay Memorial Hospital Use of PEDF-derived polypeptides for treating osteoarthritis
TWI491407B (zh) * 2012-09-20 2015-07-11 Mackay Memorial Hospital 色素上皮衍生因子衍生之多胜肽於治療骨性關節炎之用途
US9611314B2 (en) 2013-09-13 2017-04-04 The Penn State Research Foundation Functional peptide analogs of PEDF
JP6894236B2 (ja) * 2014-03-26 2021-06-30 デノボ バイオファーマ エルエルシー 免疫刺激活性を有するレトロウイルスベクター
JP6896641B2 (ja) * 2015-03-02 2021-06-30 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ 血管新生阻害ペプチド
EA037698B1 (ru) * 2016-10-07 2021-05-12 Брим Байотекнолоджи, Инк. Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
JP6469767B2 (ja) * 2017-07-05 2019-02-13 マクカイ メモリアル ホスピタル 皮膚老化を予防及び/又は改善するためのpedf−由来ポリペプチドの使用
JP6522063B2 (ja) * 2017-08-10 2019-05-29 マクカイ メモリアル ホスピタル 脱毛症及び/又は毛髪色素脱失を治療するためのpedf由来のポリペプチドの使用
AU2019253456A1 (en) * 2018-04-08 2020-11-26 Brim Biotechnology, Inc. Application of PEDF-derived short peptides in the treatment of osteoarthritis
CN111760019B (zh) * 2019-08-16 2023-09-05 董红燕 Pedf在制备保护慢性肺损伤药物中的应用
CN112390877B (zh) * 2019-08-16 2022-10-04 董红燕 Pedf衍生多肽组合物及其在制备保护肺损伤药物中的应用
EP4021917A4 (en) * 2019-08-27 2023-05-24 Yeou-Ping Tsao SHORT SYNTHETIC PEPTIDES AND THEIR USES FOR TREATING DEGENERATIVE RETINA DISEASES AND/OR TISSUE DAMAGE
JP7847082B2 (ja) * 2019-10-06 2026-04-16 ブリム バイオテクノロジー インク Pedf由来短ペプチド(pdsp)を含む組成物及びその使用
CN114057831B (zh) * 2020-08-07 2024-03-12 三凡生技研发股份有限公司 促进血管增生的短链胜肽及其促进糖尿病伤口愈合的用途
WO2025117767A1 (en) * 2023-11-29 2025-06-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modified pigment epithelium-derived factor peptides and methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010021382A1 (en) * 1991-03-29 2001-09-13 Genentech, Inc. Vascular endothelial cell growth factor antagonists
US6451763B1 (en) * 1992-06-04 2002-09-17 The United States Of America As Represented By The Department Of Health And Human Services Retinal pigmented epithelium derived neurotrophic factor and methods of use
US7105496B2 (en) * 1998-07-23 2006-09-12 Northwestern University Methods and compositions for inhibiting angiogenesis
US6821775B1 (en) * 2000-02-11 2004-11-23 Genvec, Inc. Viral vector encoding pigment epithelium-derived factor
DE60136444D1 (de) * 2000-02-23 2008-12-18 Univ Northwestern Pharmazeutische zusammensetzung zur angiogenese-hemmung mittels eines pedf-fragmentes
AU2001249835A1 (en) * 2000-04-03 2001-10-15 Oxford Glycosciences (Uk) Ltd. Diagnosis and treatment of alzheimer's disease
IL147444A0 (en) * 2002-01-03 2002-08-14 Yeda Res & Dev Process for the production of pigment epithelium derived factor (pedf) from human blood and uses thereof
US20030158112A1 (en) * 2002-02-15 2003-08-21 Johns Hopkins University School Of Medicine Selective induction of apoptosis to treat ocular disease
US20060189519A1 (en) * 2002-09-26 2006-08-24 Karl Volz Anti-angiogenic fragments fo pigment epithelium-derived factor (pedf)
AU2003297607A1 (en) * 2002-12-02 2004-06-23 Genvec, Inc Materials and methods for treating ocular-related disorders
WO2005089811A1 (en) * 2004-03-12 2005-09-29 Genvec, Inc. Materials for treating vascular leakage in the eye

Similar Documents

Publication Publication Date Title
JP2014526441A5 (enExample)
JP2011526886A5 (enExample)
CN103476933B (zh) 白介素1受体的拮抗剂
JP2013506411A5 (enExample)
JP2015504666A5 (enExample)
JP2016519134A (ja) 腎薬物標的化のためのペプチドおよびペプチド−活性成分の接合体
JP2012115277A5 (enExample)
JP2011526303A5 (enExample)
JP7834637B2 (ja) 治療用融合タンパク質
DK2994152T3 (en) CONJUGATES FOR PROTECTION AGAINST NEPHROTOXIC ACTIVE SUBSTANCES
JP2022500078A5 (enExample)
JP2014050390A5 (enExample)
JP2019533722A5 (enExample)
JP2010524968A5 (enExample)
US20210363224A1 (en) IL13Ra2 PEPTIDE AND ITS USES
JP2009535330A5 (enExample)
JP2009502803A5 (enExample)
WO2009156473A1 (en) Derivatised hybrid peptides of amylin and salmon calcitonin
JP2017524727A5 (enExample)
JP2022526367A (ja) リポカリンムテインの吸入投与
CN107949372A (zh) 烯醇酶1(Eno1)组合物及其用途
JP2025116068A (ja) 腎臓活性融合タンパク質及びそれを使用する治療方法
JP2008531463A5 (enExample)
EP4192843A1 (en) Peptides able to bind angiotensin-converting enzyme 2 (ace2) and medical uses thereof
WO2017149098A1 (en) Fusion respiratory syncytial virus inhibitors and use thereof